Journal · Updated 2026-08-11
How Much Does Semaglutide Cost in 2026? Every Channel, One Answer
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
The short answer
Semaglutide's 2026 board, floor to ceiling. Insured: $25 commercial copays where Wegovy coverage exists (the SELECT cardiovascular indication opening doors weight exclusions close), Ozempic riding diabetes formularies with a T2D diagnosis. Compounded cash: the market's lowest GLP-1 figures — $129–$139 month-to-month (bmiMD $129, HealthRX's $133 three-month, NexLife $139 promotional), $99 committed at three programs. Brand oral: NovoCare's Wegovy tablets from $149 (that tier's price holds through August 31, 2026, then $199) — the approved product camped fifty dollars from the compounded floor, the class's most interesting squeeze. Brand pens: $349 standard ($399 at the 7.2 mg tier) with a $199 introduction on the first two starter fills through year-end. Routing: coverage first; then the oral-versus-injectable-versus-compounded triangle the semaglutide flagship maps.
The annual math, and the squeeze
Twelve months, each lane: insured $300; compounded floor $1,188–$1,668 ($99 committed to $139 monthly); oral brand ~$1,988 in year one (a $149 tier's months plus the $199 tier after August — and worth re-checking as tiers move); pens ~$4,088 year one (two intro months at $199, ten at $349) or $4,188 steady-state. The squeeze deserves its own sentence: at $149-versus-$129, the FDA-approved tablet costs twenty dollars a month more than the cheapest compounded injection — no verification homework, no compounding-lane questions, manufactured product — which is the strongest brand-value argument in either molecule and the reason our semaglutide rankings route needle-averse and simplicity-first buyers there before any compounded row. What keeps compounded's half of the market: injection preference at the floor price, dose-flat economics, and the $99 committed tier the tablet can't reach. The standing rules ride along: all-ins only (membership fees inside), maintenance prices only (no "from" figures), named pharmacies only — the teaser index polices the rest.
Questions people ask
What's the cheapest semaglutide option in 2026?
Committed compounded plans at $99/month (bmiMD, HealthRX, Trimi — twelve-month terms, billing shapes vary), then $129–$139 month-to-month. The wildcard: FDA-approved oral Wegovy from $149 — $20 over the monthly compounded floor for a manufactured, approved product. Insurance beats everything where it applies.
How much is Wegovy without insurance?
Direct from NovoCare: $349/month pens ($399 for the 7.2 mg tier), with a $199 introductory price on the first two starter-dose fills through December 31, 2026 — or oral tablets from $149. Resellers charge more for the same product ($448+ all-in at Hims); the manufacturer's counter is the cash benchmark.
Is compounded semaglutide worth it versus the $149 oral tablet?
The honest close call of the class: $129–$139 compounded injectable versus $149 approved tablet is a $10–$20/month gap. The tablet buys FDA approval and zero verification homework at the cost of the strict empty-stomach ritual; compounded keeps the injection route and the $99 committed floor. Preference decides; both beat the $200+ tier.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.